Abstract

This article assesses Mexico’s organized crime alliance and subgroup network structures. Through social network…

This study finds that Maryland's all-payer model for healthcare comparatively lowered the risk of complications from surgery, as well as reducing increases in associated costs.

The authors sought to develop and test a tool that accurately predicts the unique financial burden to individual patients undergoing treatment for breast cancer. JCO Clinical Cancer Informatics, an American Society of Clinical Oncology Journal

The authors urge consideration of issues such as consent, confidentiality and return of results to ensure that the benefits of postmortem genetic testing are maximized and the harms are minimized.

Analysis of a survey conducted by the authors found that prosocial behavior plays an important role in an individual’s ability to engage in health-promoting behaviors, such as physical activity, despite adverse conditions. Journal of Behavioral Medicine, Aug. 13, 2020.

Societal inequities extend to medical and mental health research. The authors propose a framework for more equitable research that addresses disparities in mental health services and outcomes.

The "molecular autopsy," or the collection of blood and tissue for DNA analysis, is an increasingly pervasive tool in investigating sudden death in the young. The authors offer recommendations that address ethical and policy issues that arise when molecular autopsies are conducted as part of a death investigation by medical examiner or coroner offices.

The second largest percentage of new HIV infections in the United States occurs among people aged 13 to 24 years old. Yet very few state minor consent laws explicitly authorize adolescents to consent to preventive services for HIV and other sexually transmitted infections without parental permission.

In a genuine effort to protect patients from adverse events, regulatory burdens and research rigidity in clinical trials have increased to a point at which such protection is outweighing the benefits, and actually harming patients who are unable to be involved in clinical trials.